Strategies for bioanalytical method development & validation

Erik Jerks, Pharma Bioanalytical Services at Eurofins, discusses strategies for bioanalytical method development and validation, highlighting Eurofin's expertise in bioanalytical assays for biologics. The video covers three case studies that address challenges in assay development for bispecific multitarget antibodies and adeno associated virus (AAV)-based drugs. Here, Jerks underscores the importance of evolving technologies and robust automated instrumentation in tackling bioanalytical challenges from multiple angles, ultimately delivering high-quality solutions tailored to client needs. Download the free handout for further detail or contact: BioanalyticalServices@bcl.eurofins.com​ for further information.